Clinical Trial Update: Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Zanzalintinib in second-line and beyond for advanced hepatocellular carcinoma, covering Phase 1 and Phase 2, with the study not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: Northwestern University | Conditions: Advanced Hepatocellular Carcinoma, Cirrhosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING